Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic study of HP-5120 in healthy Japanese adults
jRCT2031240331Phase 1Completed
- Sponsor
- Hisamitsu Pharmaceutical Co., Inc.
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of HP-5120 (13 arms), sponsored by Hisamitsu Pharmaceutical Co., Inc. Primary endpoints: Pharmacokinetics of HP-5120 and Safety and tolerability of HP-5120. Started Oct 2024; status: completed.
02
Drugs
HP-5120
Beyond the preview
Go deeper on jRCT2031240331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031240331.